RYAN JOY: Open Payments
NPI 1417444688 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,565 in 87 payments from 15 companies in 2025. Trend: 2023 $263 · 2024 $1,646 · 2025 $1,565
Food & beverage: $1,565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $217 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $216 |
| Otsuka America Pharmaceutical, Inc. | 15 | $206 |
| Alkermes, Inc. | 9 | $191 |
| Corium, LLC | 8 | $173 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $48 |
Products named: VRAYLAR, CAPLYTA, TRINTELLIX, REXULTI, Azstarys, ARISTADA, FANAPT, Qelbree.
Industry payments across AL — which companies pay providers there.
